Immune checkpoint inhibitors (ICI) and CAR-T cell mediated cancer immunotherapy usually lead to hyper activation of IL-6, IFN- γ and other cytokines, causing severe illness and death [59], a condition similar to that observed in severe COVID-19 patients [59]. The gene discussed is IL6; the disease is COVID-19.